Loading insider details...
Beta
Latest Form 4 (Jul 2, 2026): Grant/Award of 32,000 FULC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 32,000 | n/a |
| Jun 23, 2026 | NOVAVAX INC (NVAX) | Exercise/Conversion | 18,880 | n/a |
| Jun 30, 2025 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 36,000 | n/a |
| Jun 24, 2025 | NOVAVAX INC (NVAX) | Grant/Award | 28,326 | $181.9K |
| Jun 14, 2025 | NOVAVAX INC (NVAX) | Exercise/Conversion | 10,420 | n/a |
| Jan 2, 2025 | NOVAVAX INC (NVAX) | Sale | 4,150 | $37.4K |
| Nov 14, 2024 | Fulcrum Therapeutics, Inc. (FULC) | Grant/Award | 60,000 | n/a |
| Jun 14, 2024 | NOVAVAX INC (NVAX) | Exercise/Conversion | 6,670 | n/a |
| May 1, 2024 | GLYCOMIMETICS INC (GLYC) | Grant/Award | 40,000 | n/a |
| Apr 2, 2024 | GLYCOMIMETICS INC (GLYC) | Grant/Award | 3,334 | $10.0K |